Delaflox 300 Injection

About Delaflox 300 Injection

Made by The ACME Laboratories Ltd., Delaflox 300 is a injection whose active ingredient is Delafloxacin. Doctors prescribe Delaflox 300 300 mg/vial injection to adults for acute bacterial skin and skin structure infections caused by bacteria that are susceptible to Delafloxacin.

There are 3 brands of Delafloxacin listed in Bangladesh.

What is Delaflox 300 Injection?

Delaflox 300 is a injection from The ACME Laboratories Ltd., with the generic name Delafloxacin. Doctors use it in adults for acute bacterial skin and skin structure infections caused by bacteria that are susceptible to Delafloxacin, including some staphylococcus strains. It works by interfering with the processes bacteria need to copy their genetic material, which helps stop the bacteria from multiplying. The doctor decides the dose and course.

Uses of Delaflox 300

Doctors prescribe Delaflox 300 300 mg/vial injection to adults for acute bacterial skin and skin structure infections caused by bacteria that are susceptible to Delafloxacin. It is not for viral infections or for infections that are not caused by bacteria, and it should only be used when a doctor has confirmed that an antibiotic of this kind is needed. Whether it suits your particular infection is a decision for your doctor, who will consider the cause of the infection and your overall health.

How to use Delaflox 300

Tell the doctor or pharmacist about all other medicines you take, because some medicines and supplements can interfere with this type of antibiotic. Do not inject it yourself unless a doctor has shown you how. Delaflox 300 is given as an injection by a healthcare professional. Take Delaflox 300 300 mg/vial injection exactly as your doctor tells you. The doctor decides the dose, how fast it is given and how long the course lasts. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Delaflox 300

Stop the medicine and contact your doctor straight away if you notice a skin rash or any other sign of an allergic reaction. The most common side effects reported with Delafloxacin are nausea, diarrhoea, headache, vomiting and raised liver enzymes on blood tests. Some people may have side effects while receiving Delaflox 300. Ask your doctor or pharmacist about any other reaction that worries you, and seek medical help if symptoms are severe or do not settle. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Tell the doctor before treatment if you have ever had an allergic reaction to Delafloxacin or to any quinolone antibiotic, or if you have other health problems or are taking other medicines. Ask the doctor first if you are pregnant, think you may be pregnant, or are breastfeeding. Data on use in pregnancy are limited, and there are no data on use during breastfeeding; the doctor will weigh the benefits and risks for you. Tell your doctor about all the other medicines you take.

Frequently asked questions

What does Delaflox 300 treat?

Doctors prescribe Delaflox 300 300 mg/vial injection to adults for acute bacterial skin and skin structure infections caused by bacteria that are susceptible to Delafloxacin. It is not for viral infections or for infections that are not caused by bacteria, and it should only be used when a doctor has confirmed that an antibiotic of this kind is needed.

How do I use Delaflox 300 correctly?

Tell the doctor or pharmacist about all other medicines you take, because some medicines and supplements can interfere with this type of antibiotic. Do not inject it yourself unless a doctor has shown you how.

What are the side effects of Delaflox 300?

Stop the medicine and contact your doctor straight away if you notice a skin rash or any other sign of an allergic reaction. The most common side effects reported with Delafloxacin are nausea, diarrhoea, headache, vomiting and raised liver enzymes on blood tests.

Who should be careful with Delaflox 300?

Tell the doctor before treatment if you have ever had an allergic reaction to Delafloxacin or to any quinolone antibiotic, or if you have other health problems or are taking other medicines. Ask the doctor first if you are pregnant, think you may be pregnant, or are breastfeeding.

Indications

Acute Bacterial Skin and Skin Structure Infections: Delafloxacin is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by the following susceptible microorganisms: Staphylococcus aureus (including methicillin-resistant [MRSA] ... Read moreAcute Bacterial Skin and Skin Structure Infections: Delafloxacin is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by the following susceptible microorganisms: Staphylococcus aureus (including methicillin-resistant [MRSA] and methicillin-susceptible [MSSA] isolates), Staphylococcus haemolyticus, Staphylococcus lugdunensis, Streptococcus agalactiae, Streptococcus anginosus Group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), Streptococcus pyogenes, Enterococcus faecalis, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Community-Acquired Bacterial Pneumonia: Delafloxacin is indicated in adults for the treatment of community-acquired bacterial pneumonia (CABP) caused by the following susceptible microorganisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible [MSSA] isolates only), Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus parainfluenzae, Chlamydia pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae.

Usage: To reduce the development of drug-resistant bacteria and maintain the effectiveness of Delafloxacin and other antibacterial drugs, Delafloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Pharmacology

Delafloxacin inhibits the activity of bacterial DNA topoisomerase IV and DNA gyrase (topoisomerase II). This interferes with bacterial DNA replication by preventing the relaxation of positive supercoils introduced as part of the elongation process. The resultant strain inhibits further elongation. Delafloxacin exerts concentration-dependent bacteriocidal activity.

The antibacterial activity of delafloxacin appears to best correlate with the ratio of area under the concentration-time curve of free delafloxacin to minimal inhibitory concentration (fAUC/MIC) for Gram-positive organisms such as Staphylococcus aureus and Gram-negative organisms such as Escherichia coli based on animal models of infection.

Dosage & Administration

Delafloxacin Tablets: Administer Delafloxacin at least 2 hours before or 6 hours after antacids containing magnesium, or aluminum, with sucralfate, with metal cations such as iron, or with multivitamin preparations containing zinc or iron, or with didanosine buffered tablets for oral suspension or the pediatric powder for oral solution. Delafloxacin Tablets can be taken with or without food. If patients miss a dose, they should take it as soon as possible anytime up to 8 hours prior to their next scheduled dose. If less than 8 hours remain before the next dose, wait until their next scheduled dose.

Delafloxacin Injection: Do NOT administer Delafloxacin for Injection with any solution containing multivalent cations, e.g., calcium and magnesium, through the same intravenous line. Do NOT co-infuse Delafloxacin for Injection with other medications. 

Acute bacterial skin and skin structure infections: 300 mg of Delafloxacin for Injection every 12 hours over 60 minutes by intravenous infusion Or 300 mg of Delafloxacin for Injection every 12 hours over 60 minutes by intravenous infusion, then switch to a 450 mg Delafloxacin tablet orally every 12 hours at the discretion of the physician Or 450 mg Delafloxacin tablet orally every 12 hours for 5 to 14 days.

Community-Acquired Bacterial Pneumonia: 300 mg of Delafloxacin for Injection every 12 hours over 60 minutes by intravenous infusion Or 300 mg of Delafloxacin for Injection every 12 hours over 60 minutes by intravenous infusion, then switch to a 450 mg Delafloxacin tablet orally every 12 hours at the discretion of the physician Or 450 mg Delafloxacin tablet orally every 12 hours for 5 to 10 days.

Interaction

Fluoroquinolones form chelates with alkaline earth and transition metal cations. Oral administration of Delafloxacin with antacids containing aluminum or magnesium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as didanosine buffered tablets for oral suspension or the pediatric powder for oral solution, may substantially interfere with the absorption of Delafloxacin, resulting in systemic concentrations considerably lower than desired. Therefore, Delafloxacin should be taken at least 2 hours before or 6 hours after these agents. There are no data concerning an interaction of intravenous Delafloxacin with oral antacids, sucralfate, multivitamins, didanosine, or metal cations. However, Delafloxacin should not be co-administered with any solution containing multivalent cations, e.g., magnesium, through the same intravenous line

Contraindications

Delafloxacin is contraindicated in patients with known hypersensitivity to delafloxacin or any of the fluoroquinolone class of antibacterial drugs, or any of the components of Delafloxacin.

Side Effects

Most common adverse reactions (incidence ≥2%) are nausea, diarrhea, headache, transaminase elevations, and vomiting.

Pregnancy & Lactation

Pregnancy: The limited available data with Delafloxacin use in pregnant women are insufficient to inform a drug-associated risk of major birth defects and miscarriages. When delafloxacin (as the N-methyl glucamine salt) was administered orally to rats during the period of organogenesis, no malformations or fetal death were observed at up to 7 times the estimated clinical exposure based on AUC. When rats were dosed intravenously in late pregnancy and through lactation, there were no adverse effects on offspring at exposures approximating the clinical intravenous (IV) exposure based on AUC.

Lactation: There are no data available on the presence of delafloxacin in human milk, the effects on the breast-fed infant, or the effects on milk production. Delafloxacin is excreted in the breast milk of rats. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Delafloxacin and any potential adverse effects on the breast-fed child from Delafloxacin or from the underlying maternal condition.

Precautions & Warnings

Hypersensitivity Reactions: May occur after first or subsequent doses of Delafloxacin. Discontinue Delafloxacin at the first sign of a skin rash or any other sign of hypersensitivity. Clostridium difficile-associated diarrhea: Evaluate if diarrhea occurs.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Delafloxacin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.